Gene expression correlates of clinical prostate cancer behavior
- PMID: 12086878
- DOI: 10.1016/s1535-6108(02)00030-2
Gene expression correlates of clinical prostate cancer behavior
Abstract
Prostate tumors are among the most heterogeneous of cancers, both histologically and clinically. Microarray expression analysis was used to determine whether global biological differences underlie common pathological features of prostate cancer and to identify genes that might anticipate the clinical behavior of this disease. While no expression correlates of age, serum prostate specific antigen (PSA), and measures of local invasion were found, a set of genes was identified that strongly correlated with the state of tumor differentiation as measured by Gleason score. Moreover, a model using gene expression data alone accurately predicted patient outcome following prostatectomy. These results support the notion that the clinical behavior of prostate cancer is linked to underlying gene expression differences that are detectable at the time of diagnosis.
Similar articles
-
Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.BJU Int. 2011 Jun;107(11):1748-54. doi: 10.1111/j.1464-410X.2010.09728.x. Epub 2010 Sep 30. BJU Int. 2011. PMID: 20883488
-
Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.J Urol. 2005 Dec;174(6):2181-5. doi: 10.1097/01.ju.0000181215.41607.c3. J Urol. 2005. PMID: 16280760
-
Prostate biopsy: who, how and when. An update.Can J Urol. 2005 Feb;12 Suppl 1:44-8; discussion 99-100. Can J Urol. 2005. PMID: 15780165 Review.
-
PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer.Mayo Clin Proc. 2001 Jun;76(6):576-81. doi: 10.4065/76.6.576. Mayo Clin Proc. 2001. PMID: 11393495
-
Combining prostate specific antigen with cancer and gland volume to predict more reliably pathological stage: the influence of prostate specific antigen cancer density.J Urol. 1994 Jun;151(6):1565-70. doi: 10.1016/s0022-5347(17)35303-x. J Urol. 1994. PMID: 7514689
Cited by
-
A framework for performance enhancement of classifiers in detection of prostate cancer from microarray gene.Heliyon. 2024 Apr 25;10(9):e29630. doi: 10.1016/j.heliyon.2024.e29630. eCollection 2024 May 15. Heliyon. 2024. PMID: 38720727 Free PMC article.
-
New Empirical Bayes Models to Jointly Analyze Multiple RNA-Sequencing Data in a Hypophosphatasia Disease Study.Genes (Basel). 2024 Mar 26;15(4):407. doi: 10.3390/genes15040407. Genes (Basel). 2024. PMID: 38674342 Free PMC article.
-
Ensemble methods of rank-based trees for single sample classification with gene expression profiles.J Transl Med. 2024 Feb 7;22(1):140. doi: 10.1186/s12967-024-04940-2. J Transl Med. 2024. PMID: 38321494 Free PMC article.
-
PRADclass: Hybrid Gleason Grade-Informed Computational Strategy Identifies Consensus Biomarker Features Predictive of Aggressive Prostate Adenocarcinoma.Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338231222389. doi: 10.1177/15330338231222389. Technol Cancer Res Treat. 2024. PMID: 38226611 Free PMC article.
-
MERIT: Controlling Monte-Carlo error rate in large-scale Monte-Carlo hypothesis testing.Stat Med. 2024 Jan 30;43(2):279-295. doi: 10.1002/sim.9959. Epub 2023 Nov 14. Stat Med. 2024. PMID: 38124426 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous